Search

Author/Creator Witzig, Thomas E

1. Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study. (18th August 2017)

Authors:
Cerhan, James R; Link, Brian K; Habermann, Thomas M; Maurer, Matthew J; Feldman, Andrew L; Syrbu, Sergei I; Thompson, Carrie A; Farooq, Umar; Novak, Anne J; Slager, Susan L; Allmer, Cristine; Lunde, Julianne J; Macon, William R; Inwards, David J; Johnston, Patrick B; Micallef, Ivana NM; Nowakowsk...
Journal:
International journal of epidemiology
Issue:
Volume 46:Number 6(2017)
Page Start:
1753
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Everolimus combined with R-CHOP-21 for new, untreated, diffuse large B-cell lymphoma (NCCTG 1085 [Alliance]): safety and efficacy results of a phase 1 and feasibility trial. Issue 7 (July 2016)

Authors:
Johnston, Patrick B; LaPlant, Betsy; McPhail, Ellen; Habermann, Thomas M; Inwards, David J; Micallef, Ivana N; Colgan, Joseph P; Nowakowski, Grzegorz S; Ansell, Stephen M; Witzig, Thomas E
Journal:
Lancet
Issue:
Volume 3:Issue 7(2016)
Page Start:
e309
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study. Issue 1 (January 2021)

Authors:
Adams, David; Polydefkis, Michael; González-Duarte, Alejandra; Wixner, Jonas; Kristen, Arnt V; Schmidt, Hartmut H; Berk, John L; Losada López, Inés Asunción; Dispenzieri, Angela; Quan, Dianna; Conceição, Isabel M; Slama, Michel S; Gillmore, Julian D; Kyriakides, Theodoros; Ajroud-Driss, Senda; Wa...
Journal:
Lancet neurology
Issue:
Volume 20:Issue 1(2021)
Page Start:
49
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study. Issue 1 (January 2021)

Authors:
Adams, David; Polydefkis, Michael; González-Duarte, Alejandra; Wixner, Jonas; Kristen, Arnt V; Schmidt, Hartmut H; Berk, John L; Losada López, Inés Asunción; Dispenzieri, Angela; Quan, Dianna; Conceição, Isabel M; Slama, Michel S; Gillmore, Julian D; Kyriakides, Theodoros; Ajroud-Driss, Senda; Wa...
Journal:
Lancet neurology
Issue:
Volume 20:Issue 1(2021)
Page Start:
49
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Longitudinal Toxicity over Time (ToxT) analysis to evaluate tolerability: a case study of lenalidomide in the CALGB 50401 (Alliance) trial. Issue 6 (June 2020)

Authors:
Thanarajasingam, Gita; Leonard, John P; Witzig, Thomas E; Habermann, Thomas M; Blum, Kristie A; Bartlett, Nancy L; Flowers, Christopher R; Pitcher, Brandelyn N; Jung, Sin-Ho; Atherton, Pamela J; Tan, Angelina; Novotny, Paul J; Dueck, Amylou C
Journal:
Lancet
Issue:
Volume 7:Issue 6(2020)
Page Start:
e490
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Lupus-related single nucleotide polymorphisms and risk of diffuse large B-cell lymphoma. Issue 1 (12th November 2017)

Authors:
Bernatsky, Sasha; Velásquez García, Héctor A; Spinelli, John J; Gaffney, Patrick; Smedby, Karin E; Ramsey-Goldman, Rosalind; Wang, Sophia S; Adami, Hans-Olov; Albanes, Demetrius; Angelucci, Emanuele; Ansell, Stephen M; Asmann, Yan W; Becker, Nikolaus; Benavente, Yolanda; Berndt, Sonja I; Bertrand...
Journal:
Lupus science & medicine
Issue:
Volume 4:Issue 1(2017)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Response to: 'Is rituximab effective for IgG4-related disease in the long term? Experience of cases treated with rituximab for 4 years' by Yamamoto et al. Issue 8 (28th April 2015)

Authors:
Stone, John H; Carruthers, Mollie N; Topazian, Mark D; Khosroshahi, Arezou; Witzig, Thomas E; Wallace, Zachary S; Hart, Phillip A; Deshpande, Vikram; Smyrk, Thomas C; Chari, Suresh
Journal:
Annals of the rheumatic diseases
Issue:
Volume 74:Issue 8(2015)
Page Start:
e47
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Treatment of relapsing autoimmune pancreatitis with immunomodulators and rituximab: the Mayo Clinic experience. Issue 11 (30th August 2012)

Authors:
Hart, Phil A; Topazian, Mark D; Witzig, Thomas E; Clain, Jonathan E; Gleeson, Ferga C; Klebig, Robin R; Levy, Michael J; Pearson, Randall K; Petersen, Bret T; Smyrk, Thomas C; Sugumar, Aravind; Takahashi, Naoki; Vege, Santhi S; Chari, Suresh T
Journal:
Gut
Issue:
Volume 62:Issue 11(2013)
Page Start:
1607
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗